CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparative Study of Low Doses of Rosuvastatin and Atorvastatin on Lipid and Glycemic Control in Patients with Metabolic Syndrome and Hypercholesterolemia
Jong-Seon Park, Young-Jo Kim, Ji-Yong Choi, Yoon-Nyun Kim, Teck-Jong Hong, Dong-Soo Kim, Ki-Young Kim, Myung-Ho Jeong, Jei-Keon Chae, Seok-Kyu Oh, In-Whan Seong
Korean J Intern Med. 2010;25(1):27-35.   Published online 2010 February 26    DOI:

Excel Download

Comparative Study of Low Doses of Rosuvastatin and Atorvastatin on Lipid and Glycemic Control in Patients with Metabolic Syndrome and Hypercholesterolemia
The Korean Journal of Internal Medicine. 2010;25(1):27   Crossref logo
Link1 Link2 Link3

Does rosuvastatin improve lipid levels in patients with the metabolic syndrome more effectively than atorvastatin?
Nature Clinical Practice Cardiovascular Medicine. 2006;3(2):74-75   Crossref logo
Link1 Link2 Link3

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
Trials. 2006;7(1):   Crossref logo
Link1 Link2 Link3

Atherosclerosis Supplements. 2007;8(1):196-197   Crossref logo
Link1 Link2

Ezetimibe/Simvastatin or Atorvastatin for the Treatment of Hypercholesterolemia in Patients with the Metabolic Syndrome: The VYMET Study
Current Diabetes Reports. 2010;10(3):173-175   Crossref logo
Link1 Link2 Link3

A study on the glycemic, lipid and blood pressure control of type 2 diabetes patients of Kerala
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11(4):231-235   Crossref logo
Link1 Link2

Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified by National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders. 2009;7(6):601-610   Crossref logo
Link1 Link2

The effects of triple vs. dual and monotherapy with rosiglitazone, glimepiride, and atorvastatin on lipid profile and glycemic control in type 2 diabetes mellitus rats
Fundamental & Clinical Pharmacology. 2011;26(5):621-631   Crossref logo

Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses
Journal of Clinical Lipidology. 2008;2(2):91-105   Crossref logo
Link1 Link2

Effects of pravastatin, atorvastatin, and rosuvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia
Diabetology International. 2013;4(2):117-125   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.